Torii Pharmaceutical Co Ltd
TSE:4551

Watchlist Manager
Torii Pharmaceutical Co Ltd Logo
Torii Pharmaceutical Co Ltd
TSE:4551
Watchlist
Price: 4 760 JPY 2.04% Market Closed
Market Cap: 133.8B JPY
Have any thoughts about
Torii Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Torii Pharmaceutical Co Ltd stock under the Base Case scenario is 3 177.16 JPY. Compared to the current market price of 4 760 JPY, Torii Pharmaceutical Co Ltd is Overvalued by 33%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
3 177.16 JPY
Overvaluation 33%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
1
vs Industry
55
Median 3Y
1.8
Median 5Y
1.8
Industry
2.5
Forward
2.2
vs History
30
vs Industry
24
Median 3Y
23.1
Median 5Y
23.1
Industry
21.9
Forward
26.8
vs History
19
vs Industry
0
Median 3Y
36.2
Median 5Y
2
Industry
16.5
vs History
0
vs Industry
0
Median 3Y
-29
Median 5Y
-7
Industry
23.6
vs History
0
vs Industry
65
Median 3Y
0.8
Median 5Y
0.7
Industry
2.1
vs History
0
vs Industry
69
Median 3Y
0.9
Median 5Y
0.9
Industry
2.6
Forward
1.5
vs History
0
vs Industry
66
Median 3Y
2
Median 5Y
1.8
Industry
5.2
vs History
6
vs Industry
36
Median 3Y
8.7
Median 5Y
8.5
Industry
13.3
Forward
14.1
vs History
6
vs Industry
38
Median 3Y
9.2
Median 5Y
9.4
Industry
16.6
vs History
19
vs Industry
1
Median 3Y
16.5
Median 5Y
1.1
Industry
15.6
vs History
9
vs Industry
0
Median 3Y
17.8
Median 5Y
0.5
Industry
19.1
vs History
0
vs Industry
66
Median 3Y
0.6
Median 5Y
0.5
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Torii Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Torii Pharmaceutical Co Ltd
TSE:4551
133.8B JPY 2.3 25.4 13.6 14.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
JP
Torii Pharmaceutical Co Ltd
TSE:4551
Average P/E: 31.5
25.4
65%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top